{"version":"1.0","type":"link","title":"Clinical Relevance of Starting Alectinib at a Reduced Dose in Patients with ALK-Positive Non-Small Cell Lung Cancer.","author_name":"Kim J 외","author_url":"https://prs-insight.online/author/Kim%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95031","thumbnail_width":1200,"thumbnail_height":630}